Bedrijfsprofiel
Improving the health and quality of life of humans and animals is the goal of the research-driven pharmaceutical company Boehringer Ingelheim.
Zoek op
Wereldwijde innovatie voor diergezondheid
Animal Health Global Innovation Our Global Innovation team pioneers the science that helps veterinarians, pet and livestock owners and public health officials around the world improve animal health today and in the future. We work collaboratively with our
Vee
Our livestock business encompasses the poultry, swine, ruminant segments and Veterinary Public Health to address the needs of livestock producers, livestock veterinarians, government officials and NGOs.
Myocardinfarct (hartaanval)
Information and instructional material on heart failure with reduced (HFrEF) or preserved (HFpEF) ejection fraction.
Paarden
We develop leading solutions for the wellbeing of horses in immunology, parasitology, gastric and metabolic health.
Het onderzoeksproces
A key part of our mission is to discover or identify new compounds, vaccines, technologies, disease processes, and infectious agents.
Therapeutica
We provide a disciplined scientific approach to the global discovery, development and delivery of therapeutics for all relevant animal species.
NASH
Learn more about the metabolic disease known as non-alcoholic steatohepatitis (NASH) by clicking here and visiting Boehringer Ingelheim.
Hart- en vaatziekten
Note: This webpage hosts content for general public as well as for healthcare professional and journalists & media professionals.
Luchtwegen
Find information on a variance of respiratory diseases such as asthma, COPD, idiopathic pulmonary fibrosis (IPF), Scleroderma and lung cancer.
Metacam® Pets
meloxicam
Hypertensie (hoge bloeddruk)
Effective treatment and management of hypertension are important in order to avoid further complications or risks like heart attack or stroke.
Diergezondheid: onze verantwoordelijkheid
One of the most important elements at Boehringer Ingelheim is our responsibility to protecting the connection between human, animal and environmental health.
COPD & Astma
Key goals of COPD management are to limit symptoms, reduce the risk of exacerbations and support people to live more active lives.
Onze wetenschappelijke focus
Discover where Boehringer Ingelheim's scientific research efforts and investment is currently focused on including CNS diseases, Retinal Health & COVID-19.
Verhalen
Click here to see Boehringer Ingelheim's latest featured stories. Explore our favourite stories highlighting the complex connection between animals and humans.
Kanker
At Boehringer Ingelheim we are dedicated to working on improving treatments for cancer patients everywhere with a focus on lung and gastrointestinal cancers.
vaxxitek® hvt + ibd + nd
Bursal Disease-Marek's disease-Newcastle disease vaccine, serotype 3, live Marek's disease vector; the vaccine includes a diluent
Longkanker
Boehringer Ingelheim provides innovative lung cancer treatments with specialist products for 1st and 2nd line non-small-cell lung cancer (NSCLC)
Innovaties voor menselijke gezondheid
Learn more on our goal to improve the lives of patients worldwide with medical breakthroughs and innovation, including over 100 products in the pipeline.
Data Privacy Statement – OnlineAdBoard_NL
Data Privacy Statement – OnlineAdBoard_NL
ProZinc
Protamine Zinc
Gezelschapsdieren
At Boehringer Ingelheim we think that house pets and horses should have the same level of healthcare opportunity as you do, find out more about how.
Aservo® EquiHaler®
For the alleviation of clinical symptoms of severe equine asthma characterized by coughing, nasal discharge, nasal flaring, increased breathing effort at rest,
Boehringer Ingelheim verhuist in 2022 naar Amsterdam
Boehringer Ingelheim verhuist in 2022 naar Amsterdam